DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

ViroPharma, Inc. (NASDAQ: VPHM)

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

VPHM $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $23.13 - $50.01
Market Cap $0.00
P/E Ratio 1,665.33
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.78

Sector

Healthcare

Industry

Drugs

ViroPharma, Inc. (VPHM) Description

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings. Website: http://www.viropharma.com/

News & Commentary Rss Feed

Why Did Billionaire Mario Gabelli's Company Buy Diebold, Responsys, and ViroPharma?

We small investors can get promising ideas from big investors.

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatm

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment

Mario Gabelli Comments on ViroPharma

Prem Watsa Cuts One of His 'Most Successful Investments'

Bearish Canadian Investor Prem Watsa's 7 New Positions

Mario Gabelli's Top 5 Fourth-Quarter Stock Buys

Why 2014 Could Be a Huge Year for M&A Activity

With 2014 less than a month old, there have been several major deals already. However, there could be more to come.

Shire Sells Dermagraft - Analyst Blog

Shire Quickly Pulls Off Dermagraft

Solid 2014 Expected for Shire - Analyst Blog

See More VPHM News...

VPHM's Top Competitors

VPHM $0.00 (0.00%)
Current stock: VPHM
JNJ $103.21 (0.24%)
Current stock: JNJ
NVS $88.60 (-0.03%)
Current stock: NVS
RHHBY $36.45 (-0.52%)
Current stock: RHHBY